ChemoMetec

336.20 DKK

-1.12%

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ChemoMetec

20192020202120222023202420252026
Revenue175.5214.1281.1427.2442.3407.4495.6
growth-%22.0 %31.3 %51.9 %3.5 %-7.9 %21.7 %
EBITDA64.992.6135.6222.9251.0186.2258.1-
EBIT54.177.5116.0202.9230.6169.0236.5-
Profit before taxes53.775.9112.7203.2230.4176.6240.0
Net income41.859.288.4159.5178.7136.3186.4-
EPS2.403.515.249.1610.277.8310.71-
Dividend13.0020.504.000.006.004.007.000.00
Dividend ratio540.6 %584.0 %76.3 %0.0 %58.4 %51.1 %65.4 %

Profitability and return on capital

20192020202120222023202420252026
EBITDA-%37.0 %43.3 %48.2 %52.2 %56.8 %45.7 %52.1 %
EBIT-%30.8 %36.2 %41.3 %47.5 %52.1 %41.5 %47.7 %
ROE24.1 %29.2 %33.3 %44.6 %33.5 %24.1 %27.7 %
ROI17.6 %22.5 %25.6 %31.8 %27.2 %20.1 %22.5 %